Science
Mechanism of Action
It prevents microbial spoilage by penetrating and disrupting the cytoplasmic membranes of bacteria and fungi, effectively arresting cellular enzyme activity. Structurally, its large benzyl group enhances its binding affinity to estrogen receptors, enabling it to act as a xenoestrogen more potently than shorter-chain paraben variants.
Research
Clinical Evidence
High confidence0%
Key findings
- 01 In vitro analysis identified a binding affinity for alpha-fetoprotein with an IC50 of 0.012 µM, correlating with stimulated growth in MCF-7 breast cancer cells.
- 02 Minimal Inhibitory Concentration (MIC) tests against various bacterial strains confirm efficacy between 15.62 and 250 µg/mL.
- 03 Research at the University of Sarajevo (2023) observed increased apoptotic cells in human lymphocytes at concentrations of 0.025%.
Transparency
Dusting Analysis
Because this ingredient is banned in many jurisdictions and has a safety limit of 0.0%, any presence in a modern formulation is considered a significant safety risk rather than a 'dusting' issue.
The Formula
Formulation
Stability
The molecule is stable in acidic to neutral environments but undergoes rapid hydrolysis into p-hydroxybenzoic acid and benzyl alcohol when exposed to a pH of 8.0 or higher.
Conflicts
- Non-ionic surfactants (specifically polysorbates)
- Strong oxidizing agents
- Highly alkaline environments
- Cellulose derivatives
Safety
Safety Profile
Banned for use in cosmetics in the European Union and Canada. The CIR Expert Panel determined that current data is insufficient to rule out risks regarding reproductive toxicity and potential bioaccumulation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While an effective antimicrobial, Benzylparaben is classified as a 'worst' ingredient due to its status as a potent endocrine disruptor and its subsequent ban in global regulatory markets.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources